Explore PTAB cases, litigation, UPC, and oppositions – All in one place. Find the right case faster with powerful filters and structured results.

Mylan Pharmaceuticals Inc. et al. vs. Bayer Pharma AG et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00517

Filing Date 2026-01-12

Decision Type JUDGMENT Granting Petitioners Joint and Unopposed Motion to Withdraw and Request for Adverse Judgment After Institution of Trial and on Remand 37 C.F.R. § 42.73(b)

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Bayer Pharma AG et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00517

Filing Date 2025-12-09

Decision Type Other: Fed Circuit mandate

PDF Track Case View Details

AZURITY PHARMACEUTICALS, INC. vs. Helsinn Healthcare S.A.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2025-00949

Filing Date 2025-11-19

Decision Type Decision Granting Institution of Inter Partes Review

PDF Track Case View Details

AZURITY PHARMACEUTICALS, INC. vs. Helsinn Healthcare S.A.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2025-00948

Filing Date 2025-11-19

Decision Type Decision Granting Institution of Inter Partes Review

PDF Track Case View Details

AZURITY PHARMACEUTICALS, INC. vs. Helsinn Healthcare S.A.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2025-00947

Filing Date 2025-11-19

Decision Type Decision Granting Institution of Inter Partes Review

PDF Track Case View Details

AZURITY PHARMACEUTICALS, INC. vs. Helsinn Healthcare S.A.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2025-00946

Filing Date 2025-11-19

Decision Type Decision Granting Institution of Inter Partes Review

PDF Track Case View Details

AZURITY PHARMACEUTICALS, INC. vs. Helsinn Healthcare S.A.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2025-00945

Filing Date 2025-11-19

Decision Type Institution Decision: Granting Institution of Inter Partes Review 35 U.S.C. sec. 314

PDF Track Case View Details

AZURITY PHARMACEUTICALS, INC. vs. Helsinn Healthcare S.A.

PTAB-CASES Trial Phase

Status: Trial Instituted

Proceeding Number IPR2025-00949

Filing Date 2025-05-01

Cause / Proceeding IPR

Track Case View Details

AZURITY PHARMACEUTICALS, INC. vs. Helsinn Healthcare S.A.

PTAB-CASES Trial Phase

Status: Trial Instituted

Proceeding Number IPR2025-00948

Filing Date 2025-05-01

Cause / Proceeding IPR

Track Case View Details

AZURITY PHARMACEUTICALS, INC. vs. Helsinn Healthcare S.A.

PTAB-CASES Trial Phase

Status: Trial Instituted

Proceeding Number IPR2025-00947

Filing Date 2025-05-01

Cause / Proceeding IPR

Track Case View Details

AZURITY PHARMACEUTICALS, INC. vs. Helsinn Healthcare S.A.

PTAB-CASES Trial Phase

Status: Trial Instituted

Proceeding Number IPR2025-00946

Filing Date 2025-05-01

Cause / Proceeding IPR

Track Case View Details

AZURITY PHARMACEUTICALS, INC. vs. Helsinn Healthcare S.A.

PTAB-CASES Trial Phase

Status: Trial Instituted

Proceeding Number IPR2025-00945

Filing Date 2025-05-01

Cause / Proceeding IPR

Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Sanfoi-Aventis Deutschland GmbH

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2019-01657

Filing Date 2023-08-31

Decision Type Other: Fed Circuit mandate

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Bayer Pharma AG et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00517

Filing Date 2023-07-28

Decision Type Determining All Challenged Claims Unpatentable 35 U.S.C. § 318(a)

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Bayer Pharma AG et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00517

Filing Date 2022-10-19

Decision Type Institution decision and grant of joinder, IPR2022-01513

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Bayer Pharma AG et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00517

Filing Date 2022-10-19

Decision Type Institution decision and grant of joinder, IPR2022-01515

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Bayer Pharma AG et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00517

Filing Date 2022-08-09

Decision Type Institution Decision: DECISION Granting Institution of Inter Partes Review 35 U.S.C. § 314, 37 C.F.R. § 42.4

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Bayer Pharma AG et al.

PTAB-CASES Terminated

Status: Terminated-Adverse Judgment

Proceeding Number IPR2022-00517

Filing Date 2022-02-02

Cause / Proceeding IPR

Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Sanfoi-Aventis Deutschland GmbH

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2019-01657

Filing Date 2021-03-26

Decision Type Final Written Decision Determining All Challenged Claims Unpatentable 35 U.S.C. sec 318(a) Denying in Part and Dismissing in Part Petitioner’s Motion to Exclude 37 C.F.R. sec 42.64(c)

PDF Track Case View Details

Mylan Pharmaceuticals Inc. et al. vs. Sanofi-Aventis Deutschland GmbH et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2019-00122

Filing Date 2020-05-29

Decision Type JUDGMENT Final Written Decision Determining All Challenged Claims Unpatentable Denying Petitioner’s Motion to Exclude 35 U.S.C. § 318(a)

PDF Track Case View Details